CoChat

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS

Open access
Fissolo, Nicolás, Matute-Blanch, Clara, Osman, Mohamoud, Costa, Carme, Pinteac, Rucsanda, Miró, Berta, Sanchez, Alex, Brito, Verónica, Dujmovic, Irena, Voortman, Margarete, Khalil, Michael, Borràs, Eva, Sabidó, Eduard, Issazadeh-Navikas, Shohreh, Montalban, Xavier, Comabella Lopez, Manuel · 2021 · Neurology Neuroimmunology & Neuroinflammation
Cited by 40

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Objective To identify biomarkers associated with progressive phases of MS and with neuroprotective potential. Methods Combined analysis of the transcriptional and proteomic profiles obtained in CNS tissue during chronic progressive phases of experimental autoimmune encephalomyelitis (EAE) with the transcriptional profile obtained during the differentiation of murine neural stem cells into neurons. Candidate biomarkers were measured by ELISA in the CSF of 65 patients with MS (29 with relapsing-remitting MS [RRMS], 20 with secondary progressive MS, and 16 with primary progressive MS [PPMS]) and 30 noninflammatory neurologic controls (NINCs). Results Integrative analysis of gene and protein expression data identified 2 biomarkers, the serine protease inhibitor Serpina3n and the calcium-binding protein S100A4, which were upregulated in chronic progressive EAE and whose expression was induced during neuronal differentiation. Immunofluorescence studies revealed a primarily neuronal expression of S100A4 and Serpina3n during EAE. CSF levels of SERPINA3, the human ortholog of murine Serpina3n, and S100A4 were increased in patients with MS compared with NINCs (SERPINA3: 1,320 vs 838.6 ng/mL, p = 0.0001; S100A4: 1.6 vs 0.8 ng/mL, p = 0.02). Within the MS group, CSF SERPINA3 levels were significantly elevated in patients with progressive forms, mainly patients with PPMS compared with patients with RRMS (1,617 vs 1,129 ng/mL, p = 0.02) and NINCs (1,617 vs 838.6 ng/mL, p = 0.0001). Of interest, CSF SERPINA3 levels significantly correlated with CSF neurofilament light chain levels only in the PPMS group (r = 0.62, p = 0.01). Conclusion These results point to a role of SERPINA3 as a biomarker associated with the progressive forms of MS, particularly PPMS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/nxi.0000000000000941

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 40

Metadata

Authors
Fissolo, N., Matute-Blanch, C., Osman, M., Costa, C., Pinteac, R., Miró, B., Sanchez, A., Brito, V., Dujmovic, I., Voortman, M., Khalil, M., Borràs, E., Sabidó, E., Issazadeh-Navikas, S., Montalban, X., & Comabella Lopez, M.
Venue
Neurology Neuroimmunology & Neuroinflammation
Published
2021-03-04
Volume
8
Issue
2
ISSN
2332-7812 (ISSN-L)
OpenAlex
W3121035814
Cited by
40
References
7
FWCI
3.87
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS. https://app.cochat.ai/papers/10.1212/nxi.0000000000000941
The paper
Fissolo, N., Matute-Blanch, C., Osman, M., Costa, C., Pinteac, R., Miró, B., Sanchez, A., Brito, V., Dujmovic, I., Voortman, M., Khalil, M., Borràs, E., Sabidó, E., Issazadeh-Navikas, S., Montalban, X., & Comabella Lopez, M. (2021). CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS. Neurology Neuroimmunology & Neuroinflammation. https://doi.org/10.1212/nxi.0000000000000941

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.